Coherent Stock Price, News & Analysis (NASDAQ:COHR)

Coherent trades on the NASDAQ under the ticker symbol "COHR."

Coherent declared that its board has authorized a stock repurchase plan on Thursday, February 8th 2018, which permits the company to repurchase $100,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's board of directors believes its stock is undervalued.

Coherent, Inc. (NASDAQ:COHR) released its quarterly earnings results on Tuesday, July, 30th. The scientific and technical instruments company reported $1.33 EPS for the quarter, topping the Zacks' consensus estimate of $1.05 by $0.28. The scientific and technical instruments company had revenue of $339.17 million for the quarter, compared to analyst estimates of $348.61 million. Coherent had a return on equity of 13.38% and a net margin of 8.12%. The company's quarterly revenue was down 29.7% on a year-over-year basis. During the same period in the previous year, the company earned $3.51 earnings per share. View Coherent's Earnings History.

Coherent is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Coherent.

9 analysts have issued 12-month price objectives for Coherent's stock. Their predictions range from $125.00 to $175.00. On average, they expect Coherent's share price to reach $150.00 in the next year. This suggests that the stock has a possible downside of 5.5%. View Analyst Price Targets for Coherent.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Coherent in the last year. There are currently 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Coherent.

Media coverage about COHR stock has been trending somewhat positive on Sunday, according to InfoTrie. The research group identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Coherent earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave news articles about the scientific and technical instruments company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Coherent.

Coherent saw a drop in short interest in the month of September. As of September 15th, there was short interest totalling 1,680,000 shares, a drop of 6.1% from the August 15th total of 1,790,000 shares. Based on an average trading volume of 340,500 shares, the short-interest ratio is presently 4.9 days. Currently, 7.1% of the company's shares are short sold. View Coherent's Current Options Chain.

Some companies that are related to Coherent include Waters (WAT), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories (BIO.B), PerkinElmer (PKI), Avantor (AVTR), Bruker (BRKR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM), Eyepoint Pharmaceuticals (EYPT), Harvard Bioscience (HBIO), HTG Molecular Diagnostics (HTGM) and Arrayit (ARYC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Coherent investors own include NVIDIA (NVDA), Alibaba Group (BABA), Lam Research (LRCX), Adobe (ADBE), Micron Technology (MU), Broadcom (AVGO), Netflix (NFLX), Paypal (PYPL), NetEase (NTES) and Applied Materials (AMAT).

Coherent's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Robecosam AG (0.54%), Envestnet Asset Management Inc. (0.04%), Pacer Advisors Inc. (0.04%), North Star Investment Management Corp. (0.03%), Supplemental Annuity Collective Trust of NJ (0.02%) and State of Alaska Department of Revenue (0.02%). Company insiders that own Coherent stock include Bret Dimarco, Jay T Flatley, Mark Stewart Sobey, Pamela Fletcher, Paul F Sechrist, Sandeep Vij and Stephen A Skaggs. View Institutional Ownership Trends for Coherent.

COHR stock was sold by a variety of institutional investors in the last quarter, including Supplemental Annuity Collective Trust of NJ. View Insider Buying and Selling for Coherent.

COHR stock was purchased by a variety of institutional investors in the last quarter, including Pacer Advisors Inc., Robecosam AG, Oakbrook Investments LLC, State of Alaska Department of Revenue, Envestnet Asset Management Inc., North Star Investment Management Corp., Whittier Trust Co. of Nevada Inc. and Zurcher Kantonalbank Zurich Cantonalbank . View Insider Buying and Selling for Coherent.

Shares of COHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of COHR stock can currently be purchased for approximately $158.74.

Coherent has a market capitalization of $3.81 billion and generates $1.90 billion in revenue each year. The scientific and technical instruments company earns $247.35 million in net income (profit) each year or $13.04 on an earnings per share basis. Coherent employs 5,418 workers across the globe.View Additional Information About Coherent.

The official website for Coherent is http://www.coherent.com/.

Coherent's mailing address is 5100 Patrick Henry Drive, Santa Clara CA, 95054. The scientific and technical instruments company can be reached via phone at 408-764-4000.